The right side colon cancer was found to have more BRAF mutation than left side colon cancer, which might cause the resistant to anti-EGFR therapy (Van Brummelen et al., 2017) and worsen the prognosis (Salem et al., 2017). Here, BRAF is linked to colonic neoplasm.